Efficacy, safety, and cost-effectiveness of berberine-based quadruple therapy for Helicobacter pylori infection in treatment-naive patients: a single-center randomized controlled study
Medical Journal of Chinese People′s Liberation ArmyVol. 50, Issue 11, Pages: 1414-1418(2025)
Clinical Research|更新时间:2025-12-11
分享给微信好友或者朋友圈
导出参考文献
Efficacy, safety, and cost-effectiveness of berberine-based quadruple therapy for Helicobacter pylori infection in treatment-naive patients: a single-center randomized controlled study
“According to the latest research report, berberine quadruple therapy and traditional clarithromycin quadruple therapy have comparable efficacy in eradicating Helicobacter pylori infection, but have lower incidence of adverse reactions and treatment costs, and are expected to become safe, effective, and economical treatment options.”
作者机构:
1.解放军总医院第二医学中心健康医学科,北京 100853
2.南开大学医学院,天津 300071
3.解放军总医院第一医学中心消化内科医学部,北京 100853
[临床试验注册号] ChiCTR2100050989 [中图分类号] R378 [文献标志码] A [DOI] 10.11855/j.issn.0577-7402.0949.2025.1104
Liu Dan-Dan,Sun Jiang-Shan,Tuo Yu-Jie,et al.Efficacy, safety, and cost-effectiveness of berberine-based quadruple therapy for Helicobacter pylori infection in treatment-naive patients: a single-center randomized controlled study[J].Medical Journal of Chinese People′s Liberation Army,2025,50(11):1414-1418.
Liu Dan-Dan,Sun Jiang-Shan,Tuo Yu-Jie,et al.Efficacy, safety, and cost-effectiveness of berberine-based quadruple therapy for Helicobacter pylori infection in treatment-naive patients: a single-center randomized controlled study[J].Medical Journal of Chinese People′s Liberation Army,2025,50(11):1414-1418. DOI: 10.11855/j.issn.0577-7402.0949.2025.1104.
Efficacy, safety, and cost-effectiveness of berberine-based quadruple therapy for Helicobacter pylori infection in treatment-naive patients: a single-center randomized controlled study
Safety and effectiveness of ustekinumab for Crohn's disease
Systematic review of biologic therapy safety in pregnant and breastfeeding psoriasis patients
Effects of Helicobacter pylori on gastric cancer progression by upregulating ADAMTS14 and activating Hippo signaling pathway and its underlying mechanisms
Research progress on the mechanism of metachronous gastric cancer after endoscopic submucosal dissection and Helicobacter pylori eradication in early gastric cancer
Related Author
Liu Dan-Dan
Sun Jiang-Shan
Tuo Yu-Jie
Yu Yong
Zhang Chun-Yan
Zhang Xiao-Mei
Min Han-Chen
Fan Yi-Hong
Related Institution
解放军总医院第一医学中心消化内科医学部
Department of Gastroenterology and Hepatology, the First Medical Center of Chinese PLA General Hospital
Health Medicine Department, the Second Medical Center of Chinese PLA General Hospital, Beijing 100853, China,2.School of Medicine, Nankai University
Department of Gastroenterology, the First Affiliated Hospital of Zhejiang Chinese Medical University
Department of Gastroenterology, Hangzhou Hospital of Traditional Chinese Medicine